Lucy Brady Purchases 3,470 Shares of Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works, Inc. (NYSE:BBWI) Director Lucy Brady acquired 3,470 shares of the firm’s stock in a transaction dated Friday, November 21st. The stock was bought at an average price of $14.40 per share, with a total value of $49,968.00. Following the purchase, the director directly owned 17,482 shares in the company, valued at approximately $251,740.80. This trade represents a 24.76% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Bath & Body Works Price Performance

Shares of BBWI stock traded up $0.73 during trading hours on Monday, reaching $15.58. 18,351,475 shares of the stock were exchanged, compared to its average volume of 5,908,003. The business’s fifty day moving average is $24.58 and its two-hundred day moving average is $28.11. The firm has a market capitalization of $3.21 billion, a P/E ratio of 4.62, a P/E/G ratio of 0.86 and a beta of 1.53. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm earned $0.49 EPS. The company’s revenue was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Friday, November 21st will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 5.1%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s dividend payout ratio is 24.62%.

Analyst Ratings Changes

A number of brokerages have issued reports on BBWI. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Telsey Advisory Group lowered Bath & Body Works from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $38.00 to $17.00 in a research report on Friday. Morgan Stanley reaffirmed an “equal weight” rating and issued a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a report on Friday. Bank of America cut their price objective on shares of Bath & Body Works from $40.00 to $32.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Wells Fargo & Company reduced their price objective on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $26.84.

Institutional Investors Weigh In On Bath & Body Works

Large investors have recently modified their holdings of the company. Mutual of America Capital Management LLC increased its holdings in shares of Bath & Body Works by 235.8% in the 1st quarter. Mutual of America Capital Management LLC now owns 111,471 shares of the company’s stock valued at $3,380,000 after acquiring an additional 78,280 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bath & Body Works in the first quarter valued at $807,000. Royce & Associates LP raised its holdings in shares of Bath & Body Works by 22.8% in the first quarter. Royce & Associates LP now owns 40,423 shares of the company’s stock valued at $1,226,000 after buying an additional 7,505 shares during the last quarter. Cetera Investment Advisers boosted its stake in shares of Bath & Body Works by 8.9% during the first quarter. Cetera Investment Advisers now owns 27,091 shares of the company’s stock worth $821,000 after buying an additional 2,214 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in Bath & Body Works by 1.5% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 53,593 shares of the company’s stock valued at $1,625,000 after acquiring an additional 809 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.